AIM ImmunoTech
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.About AIM
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen.
AIM Key Statistics
Stock Snapshot
The current AIM ImmunoTech(AIM) stock price is $0.70, with a market capitalization of 2.95M. The stock trades at a price-to-earnings (P/E) ratio of -0.03.
As of 2026-03-05, AIM ImmunoTech(AIM) stock has fluctuated between $0.69 and $0.70. The current price stands at $0.70, placing the stock +1.1% above today's low and -0.2% off the high.
AIM ImmunoTech(AIM) shares are trading with a volume of 7.94K, against a daily average of 245.94K.
During the past year, AIM ImmunoTech(AIM) stock moved between $0.67 at its lowest and $35.96 at its peak.
During the past year, AIM ImmunoTech(AIM) stock moved between $0.67 at its lowest and $35.96 at its peak.
AIM News
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: AIM Immunotech (...
AIM ImmunoTech (AIM) announced the preliminary results of its previously announced rights offering which expired at 5:00 p.m., Eastern Time, on March 3, 2026. T...
AIM ImmunoTech (AIM) announced an agreement with the PPD clinical research business of Thermo Fisher Scientific (TMO) to design AIM’s anticipated Phase 3 clinic...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.